Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps

    Non-penetrating glaucoma surgery: a meta-analysis of recent results

    Methodological quality of the review: Low confidence

    Author: Hondur A, Onol M, Hasanreisoglu B

    Geographical coverage: Not reported

    Sector: Glaucoma

    Sub-sector: Non-penetrating glaucoma surgery

    Equity focus: None specified

    Review type: Effectiveness review

    Quantitative synthesis method: Meta-analysis

    Qualitative synthesis method: Not applicable

    Background: For non-penetrating glaucoma surgery (NPGS), many modifications of both deep sclerectomy (DS) and viscocanalostomy (VC) have been introduced to facilitate intra-ocular pressure (IOP)-lowering efficacy. Many implants have also been used in the scleral space or in Schlemm’s canal, as well as anti-metabolite application. There is a need for clinical validation of DS and VC.

    Objectives: To evaluate the efficacy of NPGS for open angle glaucoma with respect to target intra-ocular pressure (IOP) and severity of glaucoma.

    Main findings: In this review, 30 studies were included. The percentage of cases achieving ≤21 mm Hg was 48.6% after primary DS, 68.7% after DS with implant, 67.1% after DS with anti-metabolite, 51.1% after primary VC and 36.8% after VC with anti-metabolite or implant.

    Visual field parameters were almost exclusively not available, whereas cup/disk ratio and target IOP lower than 21 mm Hg were available in very few reports. With lower-set IOP targets, the rates of success varied between 35% and 86% for DS, and between 10% and 67% for VC. The mean follow-up of the studies was mostly in the range of three years.

    The use of NPGS at an early stage of glaucoma has the benefit of avoiding adverse effects of anti-glaucoma medications on surgical success. In addition, the achievement of IOP targets in the high teens could be adequate to stop the progression of glaucoma. Authors note that longer-term studies, with data related to glaucoma severity and proper target IOPs, are required.

    Methodology: MEDLINE was searched for ‘non-penetrating glaucoma surgery’, ‘deep sclerectomy (DS)’, ‘viscocanalostomy (VC)’ and ‘open angle glaucoma’. Studies encompassing only combined glaucoma and cataract surgery were excluded. To avoid any duplication of results, multiple clinical reports – including the same cases from a single centre, the study with the largest number of cases with longer follow-up or with more clear results – was evaluated, and others excluded. Measurement of effectiveness was determined on the basis of achievement of target IOP. Data related to post-operative goniopuncture and needling with anti-metabolite application was noted.

    Applicability/external validity: No methods were used either to assess the applicability/external validity of the results or to discuss how generalizable the results are.

    Geographic focus: This review focuses on all countries, as authors did not restrict the search to specific countries.

     

    Summary of quality assessment: Low confidence was attributed in conclusions about the effects of this study as major limitations were identified. Authors did not conduct a thorough search of the literature as only MEDLINE was searched. Restriction bias was not avoided as authors included studies written in English only, and only published studies were searched for. Methods used to sift studies for inclusion, study selection, appraisal and synthesis was not clear from the review.

    Publication source: Hondur A, Onol M, Hasanreisoglu B. Non-penetrating glaucoma surgery: a meta-analysis of recent results. J Glaucoma. 2008 Mar;17(2):139-46. Source
    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.